The Hill has quoted Managing Partner Keith J. Wesley in coverage of legal and regulatory activity in the GLP-1 medication market. The article examines recent government and private announcements and actions related to the sale and marketing of compounded GLP-1 products by Hims & Hers, as well as broader legal, regulatory, and policy issues confronting companies that dispense and/or market compounded GLP-1 medications. A copy of the article can be found here: Story
Wesley has extensive experience in defending compounding pharmacies and outsourcing facilities in intellectual property, false advertising, and unfair competition litigation, including prevailing at trial and appeal in cases that have set new legal precedents that help to protect those in the compounding industry nationwide.
